Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Aisin Corporation | AKN | 22. nov 2024 | 9.80 | 0.00 |
AISIX SOLUTIONS INC. | QT7 | 22. nov 2024 | 0.01 | 0.00 |
AIXTRON SE | AIXA | 22. nov 2024 | 12.93 | +0.08 |
Aixtron SE American Depositary Receipts - Unsponsored (Germa | AIX2 | 22. nov 2024 | 24.60 | -2.38 |
AJ Bell plc | 3FY | 22. nov 2024 | 5.55 | +1.83 |
AJ Lucas Group | FW9 | 22. nov 2024 | 0.00 | 0.00 |
Ajax Resources Plc | Z8E | 22. nov 2024 | 0.02 | 0.00 |
AJINOMOTO CO. ADR 1 | AJI0 | 22. nov 2024 | 36.60 | +0.55 |
Ajinomoto Co. Inc | AJI | 22. nov 2024 | 38.54 | +2.15 |
AJISEN (CHINA) | AJN | 22. nov 2024 | 0.09 | -9.00 |
AJN Resources Inc | 5AT | 22. nov 2024 | 0.08 | 0.00 |
Akamai Technologies, Inc. | AK3 | 22. nov 2024 | 86.71 | +4.31 |
Akastor | KY7 | 22. nov 2024 | 1.11 | +1.65 |
Akatsuki Inc. | 7QT | 22. nov 2024 | 14.30 | 0.00 |
Akbank Turk Anonim Sirketi | AKB2 | 22. nov 2024 | 3.22 | +11.03 |
Akebia Therapeutics, Inc. | AX9 | 22. nov 2024 | 1.70 | +1.19 |
Aker | FKM | 22. nov 2024 | 49.80 | +1.32 |
Aker BioMarine | 1PG | 22. nov 2024 | 4.46 | +3.97 |
Aker BP | ARC | 22. nov 2024 | 20.05 | -0.10 |
Aker Carbon Capture | 606 | 22. nov 2024 | 0.49 | +0.86 |
Aker Horizons | 7QF | 22. nov 2024 | 0.15 | -11.86 |
Aker Solutions | 1AKA | 22. nov 2024 | 4.31 | +3.95 |
Akero Therapeutics, Inc. | 0K4 | 22. nov 2024 | 29.62 | +2.74 |
Akeso Inc | 4RY | 22. nov 2024 | 8.70 | +1.75 |
AKITA DRILLING A | 774 | 22. nov 2024 | 1.14 | +1.79 |
AKKO Invest Plc. | 8PL2 | 22. nov 2024 | 0.81 | +0.25 |
Akoustis Technologies, Inc. | AVH | 22. nov 2024 | 0.09 | -2.29 |
Aktia Bank | 2A41 | 22. nov 2024 | 9.02 | +0.45 |
AKVA Group | 3QI | 22. nov 2024 | 5.78 | +0.70 |
Akwel | MW4 | 22. nov 2024 | 8.09 | -2.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.